Last reviewed · How we verify
HAI conventional chemotherapy — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
HAI conventional chemotherapy (HAI conventional chemotherapy) — Association pour la Recherche sur le Temps Biologique et la Chronothérapie.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HAI conventional chemotherapy TARGET | HAI conventional chemotherapy | Association pour la Recherche sur le Temps Biologique et la Chronothérapie | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HAI conventional chemotherapy CI watch — RSS
- HAI conventional chemotherapy CI watch — Atom
- HAI conventional chemotherapy CI watch — JSON
- HAI conventional chemotherapy alone — RSS
Cite this brief
Drug Landscape (2026). HAI conventional chemotherapy — Competitive Intelligence Brief. https://druglandscape.com/ci/hai-conventional-chemotherapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab